Cogent Biosciences, Inc.
HealthcareNASDAQ:COGT · NASDAQ Global Select
+$0.47 today
Vol 1.44M · Avg 2.55M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+367.51%
Period High
$42.11
Period Low
$7.07
Latest
$33.10
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.47B
Liquidia Corporation
NASDAQ:LQDA
$6.33B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.39B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.41B
89bio, Inc.
ETNB
$2.20B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$1.92B
Galapagos N.V.
GLPG
$1.84B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$1.75B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.47B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.42B
What is the latest COGT filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does COGT have?
Intrinsic Alpha currently shows 20 recent filings for COGT.
Explore More
Continue the stock analysis
Jump to another research area for this company.